ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 630511 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 630511; 2) Community: the network communities that were significantly associated with the response to NSC 630511; 3) Molecule: the relationships between components within communities and NSC 630511; 4) MDR: the compounds that were significantly associated with the NSC 630511.

NSC Compound Enrichment Correlation
NSC 711745 Null 0.0244632509325736 0.60477055
NSC 713608 Null 0.0244632509325736 0.49713901
NSC 725191 1,6-bis[(1S,4R,5R,8R,12R,13S)-1,5-dimethyl-10-(trifluorometh yl)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexade c-9-en-9-yl]-3-hexene-1,6-diol 0.0244632509325736 0.61444867
NSC 731201 ethyl 6,7-dichloro-3-phenyl-2-quinoxalincarboxylate 1,4-dioxide 0.0244632509325736 0.41742215
NSC 736164 pyrazoline derivative 0.0244632509325736 0.49799414
NSC 736914 Null 0.0244632509325736 0.58724627
NSC 740385 7-fluoro-2-benzoyl-3-trifluoromethylquioxaline 1,4-dioxide 0.0244632509325736 0.62647612
NSC 740602 Null 0.0244632509325736 0.52452245
NSC 747452 3,19-(4-Acetamido)benzylidineandrographolide 0.0244632509325736 0.52171928
NSC 763646 (E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole 0.0244632509325736 0.51962857
Total:104  Current:65    [First] [Prev] [Next] [Last]